![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bioventus Inc. Class A Common Stock (MM) | NASDAQ:BIOV | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
Bioventus Inc.
(Exact name of registrant as specified in its charter)
Delaware | 81-090861 | |
(State or incorporation or organization) | (IRS Employer Identification No.) | |
4721 Emperor Boulevard, Suite 100 Durham, NC |
27703 | |
(Address of Principal Executive Offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be so registered |
Name of each exchange on which each class is to be registered |
|
Class A common stock, par value $0.001 per share | The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨
Securities Act registration statement file number to which this form relates: 333-212329.
Securities to be registered pursuant to Section 12(g) of the Act: None.
Item 1. Description of Registrants Securities to be Registered.
The description of the Class A common stock, par value $0.001 per share, of Bioventus Inc. (the Company) as included under the caption Description of capital stock in the Prospectus forming a part of the Companys Registration Statement on Form S-1, originally filed with the Securities and Exchange Commission (the Commission) on June 30, 2016 (File No. 333-212329) and as subsequently amended (the Registration Statement), is hereby incorporated by reference. In addition, all of the above-referenced descriptions included in any Prospectus relating to the Registration Statement filed with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.
Item 2. Exhibits.
Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
2
SIGNATURES
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Durham, state of North Carolina, on the 26th day of July, 2016.
Date: July 26, 2016 | BIOVENTUS INC. | |||||
By: |
/s/ David J. Price |
|||||
Name: | David J. Price | |||||
Title: | Chief Financial Officer |
3
1 Year BIOVENTUS INC. Chart |
1 Month BIOVENTUS INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions